Results 21 to 30 of about 273 (147)
CLOZAPINE TREATMENT IN BIPOLAR AND SCHIZOAFFECTIVE DISORDERS: A RETROSPECTIVE STUDY
Psychiatry and Clinical Psychopharmacology, 2021 Object: The aim of this study is to evaluate the sociodemographic and clinical features and efficacy of clozapine treatment in patients with bipolar disorder (BD) and schizoaffective disorder (SD).
Özen Önen Sertöz +2 more
doaj
Tedaviye Dirençli Katatonik Şizofrenide Klozapin Başlangıcı için Lityum Kullanımı
Turk Psikiyatri DergisiMerve Simay Ediş +3 more
exaly +2 more sources
Clozapine in the Treatment of Tardive Dyskinesia: Three Case Reports
Psychiatry and Clinical Psychopharmacology, 2021 The causes and the pathogenesis of tardive dyskinesia (TD) are not well understood. There is no consistently successful treatment for TD. Symptoms of TD could be suppressed by clozapine.
Özcan UZUN +3 more
doaj
JPSCR: Journal of Pharmaceutical Science and Clinical Research, 2023 Terapi kombinasi antispikotik digunakan pada pasien skizofrenia untuk meningkatkan efikasi namun berpotensi untuk terjadinya masalah terkait terapi obat akibat dari interaksi.
Sunandar Ihsan +3 more
doaj +1 more source
A COMPARISON OF EFFICACY AND SAFETY OF CLOZAPINE AND SULPIRIDE IN TREATMENT-RESISTANT SCHIZOPHRENIA
Psychiatry and Clinical Psychopharmacology, 2021 Object: In this study, a comparison of efficacy and tolerability of clozapine and sulpiride on treatment-resistant-schizophrenia was aimed. Method: Thirty-six in-patients with treatment-resistant schizophrenia, diagnosed according to DSM-IV diagnostic
Hasan Herken +4 more
doaj
Psychiatry and Clinical Psychopharmacology, 2021 Objective: Clozapine is a well-known atypical antipsychotic agent which is especially useful in patients with treatment-resistant schizophrenia, but there is still debate on its potential to cause arrhythmia and sudden death.
Mevhibe N. Tümüklü +8 more
doaj
Combination treatments in schizophrenia
Psychiatry and Clinical Psychopharmacology, 2021 Use of multiple antipsychotic agents in patients with schizophrenia, especially in treatment resistant schizophrenia, is common practice in psychiatry, although most schizophrenia guidelines recommend monotherapy.
Vesile Altınyazar, Nevzat Yüksel
doaj +1 more source
Pimozide augmentation of clozapin: A case report
Psychiatry and Clinical Psychopharmacology, 2021 Although clozapine is the gold standard in treatment of resistant schizophrenia, it is ineffective at more than 50% of patients and needs augmentation therapies.
Mine Ergelen +2 more
doaj
Psychiatry and Clinical Psychopharmacology, 2021 Clozapine is one of the most effective drugs in treatment resistant schizophrenia, schizoaffective and bipolar disorder. There is limited evidence to support the combination of multiple antipsychotics in treatment resistant schizophrenia, in the ...
Hayriye Dilek Yalvaç +4 more
doaj
Augmentation of clozapine with aripiprazole in treatment-resistent schizophrenia: A case report
Psychiatry and Clinical Psychopharmacology, 2021 Clozapine is the treatment of choice for non-responder schizophrenic patients, with beneficial effects in terms of mental state and suicide mortality.
Osman Yıldırım +4 more
doaj